DOJ, SEC Investigating GlaxoSmithKline for Possible FCPA Violations
By Mary Jacoby | August 13, 2010 12:21 pm

The Justice Department and Securities and Exchange Commission are investigating the pharmaceutical giant, GlaxoSmithKline, for possible violations of the Foreign Corrupt Practices Act, the Financial Times reported.

It has been known for months that the DOJ’s Criminal Fraud Section and the SEC are investigating several pharmaceutical companies for potential FCPA violations. But it has not been publicly known that Glaxo Smith Kline was one of companies under scrutiny.

In April, the DOJ and SEC sent letters to at least five other major pharmaceutical companies: AstraZeneca PLC; Baxter International Inc.; Eli Lilly & Co.; Bristol-Myers Squibb Co.; and Merck & Co

The letters, which were later described to Main Justice, said the agencies were focusing on the companies’ business in several countries, which varied by firm but included Brazil, China, Germany, Greece, Italy, Poland, Russia and Saudi Arabia.

GlaxoSmithKline told FT that it had received “inquiries” from US authorities, but that it disclosed the issue only “reactively,” telling only a few reporters in April. However, the inquiry into the company was not disclosed in news reports at the time.

An industry attorney familiar with the probe told FT the Justice Department was looking at whether the companies had ignored a “systematic risk” inherent in the global drugs business, though it is not clear precisely what activity is under investigation.

Facebook Twitter Linkedin Email

61 Comments

  1. Anderson says:

    …Check this out…

    [...]Wow, superb weblog structure! How lengthy have you ever been running a blog for?[...]…

  2. NBA Picks says:

    [...]the time to read or visit the content or sites we have linked to below the[...]……

    [...]here are some links to sites that we link to because we think they are worth visiting[...]……

  3. modele photo says:

    Trackback…

    [...]The total glance of your site is great, let smartly as the content![...]…

  4. bike games says:

    Websites we think you should visit…

    [...]although websites we backlink to below are considerably not related to ours, we feel they are actually worth a go through, so have a look[...]……

  5. tatuaggi says:

    Blogs ou should be reading…

    [...]Here is a Great Blog You Might Find Interesting that we Encourage You[...]……

Leave a Comment

You must be logged in to post a comment.

Ernst & Young LLP
Dealing with complex issues of fraud, regulatory compliance and business disputes can detract from efforts to succ... more
Barnes & Thornburg LLP
ANALYSIS: Insurance and White Collar Defense: If You Don't Have One, You May Not be Able to Have the Other more
Paul Hastings LLP
ANALYSIS: Executives Beware: The Long-Arm of the U.S. Government Strikes Again more
Debevoise & Plimpton LLP
ANALYSIS:  DOJ Re-addresses Issues Arising When a Business Partner Becomes a Foreign Official more
David M. Quinones
David Quinones is a former reporter for the Miami Herald with extensive experience writing about money laundering,... more
Orrick, Herrington & Sutcliffe LLP
ANALYSIS: SEC Says Lack of Internal Controls Led to HP Paying Over $108M to Settle FCPA Actions more

NEW: NEW JERSEY GOV. CHRISTIE PROBE: Manhattan District Attorney Cyrus Vance Jr. is investigating Chris Christie capo David Samson's operations at the NY/NJ Port Authority. Main Justice's Mary Jacoby discusses with Alex Wagner on MSNBC.



LISA BRENNAN ON RACHEL MADDOW SHOW: The MSNBC host interviewed Main Justice contributor Lisa Brennan about her scoops in the Chris Christie Bridgegate scandal.


RACHEL MADDOW SEGMENT ON MAIN JUSTICE'S SCOOPS: The MSNBC host details Main Justice's exclusive reporting on New Jersey U.S. Attorney Paul Fishman's probe of the George Washington Bridge lane closures.